tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Novartis Ag (NVS)
NYSE:NVS
US Market
NVS
Novartis
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Novartis (NVS) Stock News & Sentiment

Compare
3,658 Followers
Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
Premium
Market News
Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
6d ago
DYN
NVS
Amgen (NASDAQ:AMGN) to Invest $200M in India High Tech Site as Trump Tariffs Loom 
Premium
Market News
Amgen (NASDAQ:AMGN) to Invest $200M in India High Tech Site as Trump Tariffs Loom 
30d ago
LLY
MDT
Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?
Premium
Market News
Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?
1M ago
NVS
PFE
Hold Rating for Novartis AG Due to Limited Potential of Abelacimab Despite Acquisition of Anthos Therapeutics
Premium
Ratings
Hold Rating for Novartis AG Due to Limited Potential of Abelacimab Despite Acquisition of Anthos Therapeutics
1M ago
NVS
M&A News: Novartis Seals $3.1B Deal to Acquire Anthos
Premium
Market News
M&A News: Novartis Seals $3.1B Deal to Acquire Anthos
1M ago
BX
JNJ
Novartis AG Earnings Call Highlights Strong Growth and Strategic Challenges
Premium
Company Announcements
Novartis AG Earnings Call Highlights Strong Growth and Strategic Challenges
2M ago
NVS
Navigating Risks: Novartis’s Strategic Challenges in Expanding Innovative Medicines Portfolio
Premium
Company Announcements
Navigating Risks: Novartis’s Strategic Challenges in Expanding Innovative Medicines Portfolio
2M ago
NVS
More NVS News >

NVS News on the Web

5 Large Drug Stocks to Watch as Industry Recovers
Zacks
Neutral
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Zacks
Bullish
Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains
Zacks
Neutral
Kepler Capital Keeps Their Buy Rating on Novartis AG (NOVN)
TipRanks News
Neutral
FDA Approves Novartis Drug for Rare Kidney Disease Treatment
Zacks
Neutral
Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy
Zacks
Neutral
Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals
Zacks
Neutral
Morgan Stanley says Fabhalta's label leaves opportunity for Apellis' Empaveli
The Fly
Neutral

News Score - Last 7 Days

Neutral
NVS
Sector Average
Media Buzz
This Week8 articles
Weekly Average8.5 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NVS’s Media Buzz Sentiment?
8 articles about NVS were published this week. In an average week, 8.5 articles are published.
    What is NVS’s weekly average amount of articles?
    In an average week, 8.5 articles about NVS are published.
      What is NVS’s News Sentiment?
      50% of articles about NVS were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        PLXProtalix
        DVAXDynavax
        OGNOrganon
        IMVTImmunovant
        RBOTVicarious Surgical
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing